RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
ANNALS OF ONCOLOGY : OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Collezione AO Ordine Mauriziano

Items : 9

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2024 Jul;35(7):667-676. doi: 10.1016/j.annonc.2024.04.007. Epub 2024 May 3.

2024
AO Ordine Mauriziano

Perrone F; Salutari V; De Angelis C; Carbone V; Russo D; Turinetto M; Spina A; Greco F; Scognamiglio G; De Cecio R; Scaglione GL; Arcangeli V; Tamberi S; Capoluongo ED; Priolo D; Mignogna C; Pignata S; Califano D; Passarelli A; Cinieri S; Farolfi A; Lombardi D; Scambia G; Pisano C; Andreetta C; De Giorgi U; Bartoletti M; Casartelli C; Arenare L; et alii...

Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2024 Aug;35(8):728-738. doi: 10.1016/j.annonc.2024.05.546. Epub 2024 Jun 10.

2024
AO Ordine Mauriziano

McCourt C; Mirza MR; Stevens S; Grimshaw M; Balas MM; Ring KL; Herzog TJ; Slomovitz BM; Buscema J; Coleman RL; Monk BJ; Pothuri B; Sebastianelli A; Shahin MS; Gennigens C; Segev Y; Gill SE; Gold MA; Boere I; Stuckey A; Lai DW; Gropp-Meier M; Landrum LM; Valabrega G; Sharma S; Gilbert L; Black D; Novák Z; Willmott L; et alii...

Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit? in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Jul;34(7):567-568. doi: 10.1016/j.annonc.2023.05.011.

2023
AO Ordine Mauriziano

Mosele F; Di Maio M;

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Sep;33(9):878-892. doi: 10.1016/j.annonc.2022.04.007. Epub 2022 Apr 21.

2022
AO Ordine Mauriziano

Santini D; Ripamonti CI; Freeman-Daily J; Apostolidis K; Zhang L; Warrington L; Sundaresan P; Stover AM; Perrone F; Howell D; Kowalski C; Ganz PA; Denis F; Fallowfield LJ; Di Maio M; Basch E;

The systemic treatment of recurrent ovarian cancer revisited. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2021 Jun;32(6):710-725. doi: 10.1016/j.annonc.2021.02.015. Epub 2021 Mar 3.

2021
AO Ordine Mauriziano

Baert T; Ferrero A; Sehouli J; O'Donnell DM; González-Martín A; Joly F; van der Velden J; Blecharz P; Tan DSP; Querleu D; Colombo N; du Bois A; Ledermann JA;

Lessons from clinical trials on quality-of-life assessment in ovarian cancer trials. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Jun;27(6):961-962. doi: 10.1093/annonc/mdw153. Epub 2016 Apr 7.

2016
AO Ordine Mauriziano

Di Maio M; Perrone F;

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 May;23(5):1185-1189. doi: 10.1093/annonc/mdr441. Epub 2011 Oct 5.

2012
AO Ordine Mauriziano

Gladieff L; Ferrero A; De Rauglaudre G; Brown C; Vasey P; Reinthaller A; Pujade-Lauraine E; Reed N; Lorusso D; Siena S; Helland H; Elit L; Mahner S;

Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Aug;23(8):2020-2027. doi: 10.1093/annonc/mdr583. Epub 2012 Jan 30.

2012
AO Ordine Mauriziano

Brundage M; Gropp M; Mefti F; Mann K; Lund B; Gebski V; Wolfram G; Reed N; Pignata S; Ferrero A; Brown C; Eisenhauer E; Pujade-Lauraine E;

Malignant lymphoproliferative disorders in liver cirrhosis. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 1993 Mar;4(3):245-50. doi: 10.1093/oxfordjournals.annonc.a058465.

1993
AO Ordine Mauriziano

Lombardo L; Rota Scalabrini D; Vineis P; De La Pierre M;